logo
Plus   Neg
Share
Email

Pfizer & BioNTech Report Encouraging Findings On Vaccine's Effectiveness In Neutralizing U.K. Strain

Pfizer Inc. (PFE) and BioNTech SE (BNTX) said results from an in vitro study showed their COVID-19 vaccine elicited antibodies that neutralize pseudovirus bearing the SARS-CoV-2 U.K. strain spike protein in cell culture. The current in-vitro study investigated the full set of UK strain spike mutations.

Pfizer and BioNTech said they are encouraged by these early in vitro study findings. The companies noted that further data are needed to monitor their COVID-19 vaccine's effectiveness in preventing COVID-19 caused by new virus variants.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration said that it will rapidly work toward finalization and issuance of an emergency use authorization of Johnson & Johnson's (JNJ) single-shot COVID-19 vaccine candidate. Billionaire Warren Buffett's Berkshire Hathaway Inc. (BRK.A, BRK.B) reported that its fourth-quarter net earnings attributable to shareholders rose 23 percent to $35.84 billion from last year's $29.16 billion, with earnings per share improving to $23,015 per Class A share from $17,909 per Class A share in the prior year. Walmart Inc. has launched a nationwide drive to boost COVID-19 vaccination rates by reaching out to more residents in vulnerable communities. The retail giant will organize a series of community events at 43 locations in 18 states to administer the COVID-19 vaccine. Walmart said it plans to continue these new events over the next several weeks as vaccine allocations allow.
Follow RTT